Biopharma Bucking Market Trends on Positive FDA Feedback
31 Octobre 2024 - 6:00PM
AllPennyStocks.com
This firm’s treatment for a disfiguring skin infection has
demonstrated safety and efficacy across multiple Phase 2 and Phase
3 studies, and shares are holding their own despite
today's...
To read the full story on AllPennyStocks.com, click
here.
Appili Therapeutics (TSX:APLI)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Appili Therapeutics (TSX:APLI)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024